JOURNAL OF NEUROCHEMISTRY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2177893, encodeId=e24121e78939e, content=中科院分区太过分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Fri Dec 29 00:08:32 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159781, encodeId=65fb2159e8138, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经炎症 经验分享：5.5 submitted 5.8 Under review 5.10 Under Review 6.12 Major revision 8.23 submited 8.25 under review 9.1 Under Review 9.22 Awaiting Decision 9.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bda8651849, createdName=ms3000002118825560, createdTime=Tue Sep 26 11:05:43 CST 2023, time=2023-09-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=964796, encodeId=efdc964e9609, content=审稿速度:6.0 经验分享：4月16接收综述一篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Wed May 12 07:59:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197686, encodeId=e65b119e68614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;生物标志物 经验分享：IF 5.372 2021/11/16 Awaiting Admin Processing, Under Review 2021/11/17 Under review 2021/12/09 Under Review 2022/01/13 催稿信 2022/01/14 Major Revision 2022/01/17 补发Referee3意见 2022/02/23 Awaiting Admin Processing 2022/02/24 Minor revision, Awaiting Admin Processing, Under Review 2022/02/25 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Sun Feb 27 10:02:51 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564192, encodeId=09755641921f, content=你的文章怎么样了qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, beContent=qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=556b1436955, createdName=gunaibing, createdTime=Sat Dec 08 00:00:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583266, encodeId=a801583266da, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8月30投稿，国庆返修，大修给了3个月时间，2个reviewer+编辑部大大小小40+个问题，为了毕业咬牙补了2个实验，response写了近7k,文章最后几乎重写，截稿最后一天最后1个小时修回去，天天刷网页，好在一周后accept。不得不说，编辑都挺仔细的，希望今年能破5。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/a27b6b8db8d90fcd7110b426c39f0062/4ed52214cfc264eaf29fcd0493834b5b.jpg, createdBy=fd2f1702643, createdName=正经可乐, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581398, encodeId=df6758139879, content=请问大家如果作者单位没有搜索到该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/31/8d861a664fc3e3e6d49b017cf9a9307f.jpg, createdBy=dcfd5205856, createdName=但行好事莫问前程, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580294, encodeId=c4ba5802943c, content=怎么哪里都有你而且全是灌水发言 132****5832暂无昵称 2019-10-25 发表:: 求经验求分享132****5832暂无昵称 2019-10-25 00:00:00 发表: 求经验求分享, beContent=132****5832暂无昵称 2019-10-25 发表:: 求经验求分享, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/d8b6f67634df60e1fc4d6be63d990ad2.jpg, createdBy=da341701496, createdName=Jesny, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578780, encodeId=68065e8780bc, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569362, encodeId=2bd35693626e, content=问下后来接收了吗，特别感激178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗178ot344101(暂无昵称) 2018-03-28 00:00:00 发表: 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, beContent=178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/b1048959fe9b121edb8df1193c53299b.jpg, createdBy=f95e2215637, createdName=小龙虾哒哒, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=)]

2023-12-29 ms1000001139242253 来自浙江省

中科院分区太过分了

19 0

[GetPortalCommentsPageByObjectIdResponse(id=2177893, encodeId=e24121e78939e, content=中科院分区太过分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Fri Dec 29 00:08:32 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159781, encodeId=65fb2159e8138, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经炎症 经验分享：5.5 submitted 5.8 Under review 5.10 Under Review 6.12 Major revision 8.23 submited 8.25 under review 9.1 Under Review 9.22 Awaiting Decision 9.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bda8651849, createdName=ms3000002118825560, createdTime=Tue Sep 26 11:05:43 CST 2023, time=2023-09-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=964796, encodeId=efdc964e9609, content=审稿速度:6.0 经验分享：4月16接收综述一篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Wed May 12 07:59:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197686, encodeId=e65b119e68614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;生物标志物 经验分享：IF 5.372 2021/11/16 Awaiting Admin Processing, Under Review 2021/11/17 Under review 2021/12/09 Under Review 2022/01/13 催稿信 2022/01/14 Major Revision 2022/01/17 补发Referee3意见 2022/02/23 Awaiting Admin Processing 2022/02/24 Minor revision, Awaiting Admin Processing, Under Review 2022/02/25 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Sun Feb 27 10:02:51 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564192, encodeId=09755641921f, content=你的文章怎么样了qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, beContent=qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=556b1436955, createdName=gunaibing, createdTime=Sat Dec 08 00:00:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583266, encodeId=a801583266da, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8月30投稿，国庆返修，大修给了3个月时间，2个reviewer+编辑部大大小小40+个问题，为了毕业咬牙补了2个实验，response写了近7k,文章最后几乎重写，截稿最后一天最后1个小时修回去，天天刷网页，好在一周后accept。不得不说，编辑都挺仔细的，希望今年能破5。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/a27b6b8db8d90fcd7110b426c39f0062/4ed52214cfc264eaf29fcd0493834b5b.jpg, createdBy=fd2f1702643, createdName=正经可乐, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581398, encodeId=df6758139879, content=请问大家如果作者单位没有搜索到该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/31/8d861a664fc3e3e6d49b017cf9a9307f.jpg, createdBy=dcfd5205856, createdName=但行好事莫问前程, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580294, encodeId=c4ba5802943c, content=怎么哪里都有你而且全是灌水发言 132****5832暂无昵称 2019-10-25 发表:: 求经验求分享132****5832暂无昵称 2019-10-25 00:00:00 发表: 求经验求分享, beContent=132****5832暂无昵称 2019-10-25 发表:: 求经验求分享, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/d8b6f67634df60e1fc4d6be63d990ad2.jpg, createdBy=da341701496, createdName=Jesny, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578780, encodeId=68065e8780bc, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569362, encodeId=2bd35693626e, content=问下后来接收了吗，特别感激178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗178ot344101(暂无昵称) 2018-03-28 00:00:00 发表: 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, beContent=178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/b1048959fe9b121edb8df1193c53299b.jpg, createdBy=f95e2215637, createdName=小龙虾哒哒, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=)]

2023-09-26 ms3000002118825560 来自湖北省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：神经炎症
经验分享：5.5 submitted
5.8 Under review
5.10 Under Review
6.12 Major revision
8.23 submited
8.25 under review
9.1 Under Review
9.22 Awaiting Decision
9.23 Accept

33 0

[GetPortalCommentsPageByObjectIdResponse(id=2177893, encodeId=e24121e78939e, content=中科院分区太过分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Fri Dec 29 00:08:32 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159781, encodeId=65fb2159e8138, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经炎症 经验分享：5.5 submitted 5.8 Under review 5.10 Under Review 6.12 Major revision 8.23 submited 8.25 under review 9.1 Under Review 9.22 Awaiting Decision 9.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bda8651849, createdName=ms3000002118825560, createdTime=Tue Sep 26 11:05:43 CST 2023, time=2023-09-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=964796, encodeId=efdc964e9609, content=审稿速度:6.0 经验分享：4月16接收综述一篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Wed May 12 07:59:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197686, encodeId=e65b119e68614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;生物标志物 经验分享：IF 5.372 2021/11/16 Awaiting Admin Processing, Under Review 2021/11/17 Under review 2021/12/09 Under Review 2022/01/13 催稿信 2022/01/14 Major Revision 2022/01/17 补发Referee3意见 2022/02/23 Awaiting Admin Processing 2022/02/24 Minor revision, Awaiting Admin Processing, Under Review 2022/02/25 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Sun Feb 27 10:02:51 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564192, encodeId=09755641921f, content=你的文章怎么样了qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, beContent=qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=556b1436955, createdName=gunaibing, createdTime=Sat Dec 08 00:00:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583266, encodeId=a801583266da, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8月30投稿，国庆返修，大修给了3个月时间，2个reviewer+编辑部大大小小40+个问题，为了毕业咬牙补了2个实验，response写了近7k,文章最后几乎重写，截稿最后一天最后1个小时修回去，天天刷网页，好在一周后accept。不得不说，编辑都挺仔细的，希望今年能破5。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/a27b6b8db8d90fcd7110b426c39f0062/4ed52214cfc264eaf29fcd0493834b5b.jpg, createdBy=fd2f1702643, createdName=正经可乐, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581398, encodeId=df6758139879, content=请问大家如果作者单位没有搜索到该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/31/8d861a664fc3e3e6d49b017cf9a9307f.jpg, createdBy=dcfd5205856, createdName=但行好事莫问前程, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580294, encodeId=c4ba5802943c, content=怎么哪里都有你而且全是灌水发言 132****5832暂无昵称 2019-10-25 发表:: 求经验求分享132****5832暂无昵称 2019-10-25 00:00:00 发表: 求经验求分享, beContent=132****5832暂无昵称 2019-10-25 发表:: 求经验求分享, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/d8b6f67634df60e1fc4d6be63d990ad2.jpg, createdBy=da341701496, createdName=Jesny, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578780, encodeId=68065e8780bc, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569362, encodeId=2bd35693626e, content=问下后来接收了吗，特别感激178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗178ot344101(暂无昵称) 2018-03-28 00:00:00 发表: 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, beContent=178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/b1048959fe9b121edb8df1193c53299b.jpg, createdBy=f95e2215637, createdName=小龙虾哒哒, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=)]

2021-05-12 ms1000000382906414

审稿速度:6.0
经验分享：4月16接收综述一篇。

136 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2177893, encodeId=e24121e78939e, content=中科院分区太过分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Fri Dec 29 00:08:32 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159781, encodeId=65fb2159e8138, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经炎症 经验分享：5.5 submitted 5.8 Under review 5.10 Under Review 6.12 Major revision 8.23 submited 8.25 under review 9.1 Under Review 9.22 Awaiting Decision 9.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bda8651849, createdName=ms3000002118825560, createdTime=Tue Sep 26 11:05:43 CST 2023, time=2023-09-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=964796, encodeId=efdc964e9609, content=审稿速度:6.0 经验分享：4月16接收综述一篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Wed May 12 07:59:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197686, encodeId=e65b119e68614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;生物标志物 经验分享：IF 5.372 2021/11/16 Awaiting Admin Processing, Under Review 2021/11/17 Under review 2021/12/09 Under Review 2022/01/13 催稿信 2022/01/14 Major Revision 2022/01/17 补发Referee3意见 2022/02/23 Awaiting Admin Processing 2022/02/24 Minor revision, Awaiting Admin Processing, Under Review 2022/02/25 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Sun Feb 27 10:02:51 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564192, encodeId=09755641921f, content=你的文章怎么样了qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, beContent=qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=556b1436955, createdName=gunaibing, createdTime=Sat Dec 08 00:00:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583266, encodeId=a801583266da, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8月30投稿，国庆返修，大修给了3个月时间，2个reviewer+编辑部大大小小40+个问题，为了毕业咬牙补了2个实验，response写了近7k,文章最后几乎重写，截稿最后一天最后1个小时修回去，天天刷网页，好在一周后accept。不得不说，编辑都挺仔细的，希望今年能破5。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/a27b6b8db8d90fcd7110b426c39f0062/4ed52214cfc264eaf29fcd0493834b5b.jpg, createdBy=fd2f1702643, createdName=正经可乐, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581398, encodeId=df6758139879, content=请问大家如果作者单位没有搜索到该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/31/8d861a664fc3e3e6d49b017cf9a9307f.jpg, createdBy=dcfd5205856, createdName=但行好事莫问前程, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580294, encodeId=c4ba5802943c, content=怎么哪里都有你而且全是灌水发言 132****5832暂无昵称 2019-10-25 发表:: 求经验求分享132****5832暂无昵称 2019-10-25 00:00:00 发表: 求经验求分享, beContent=132****5832暂无昵称 2019-10-25 发表:: 求经验求分享, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/d8b6f67634df60e1fc4d6be63d990ad2.jpg, createdBy=da341701496, createdName=Jesny, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578780, encodeId=68065e8780bc, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569362, encodeId=2bd35693626e, content=问下后来接收了吗，特别感激178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗178ot344101(暂无昵称) 2018-03-28 00:00:00 发表: 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, beContent=178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/b1048959fe9b121edb8df1193c53299b.jpg, createdBy=f95e2215637, createdName=小龙虾哒哒, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=)]

2022-02-27 雪亦飘零久

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：帕金森病;生物标志物
经验分享：IF 5.372
2021/11/16 Awaiting Admin Processing, Under Review
2021/11/17 Under review
2021/12/09 Under Review
2022/01/13 催稿信
2022/01/14 Major Revision
2022/01/17 补发Referee3意见
2022/02/23 Awaiting Admin Processing
2022/02/24 Minor revision, Awaiting Admin Processing, Under Review
2022/02/25 Accept

62 0

[GetPortalCommentsPageByObjectIdResponse(id=2177893, encodeId=e24121e78939e, content=中科院分区太过分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Fri Dec 29 00:08:32 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159781, encodeId=65fb2159e8138, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经炎症 经验分享：5.5 submitted 5.8 Under review 5.10 Under Review 6.12 Major revision 8.23 submited 8.25 under review 9.1 Under Review 9.22 Awaiting Decision 9.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bda8651849, createdName=ms3000002118825560, createdTime=Tue Sep 26 11:05:43 CST 2023, time=2023-09-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=964796, encodeId=efdc964e9609, content=审稿速度:6.0 经验分享：4月16接收综述一篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Wed May 12 07:59:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197686, encodeId=e65b119e68614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;生物标志物 经验分享：IF 5.372 2021/11/16 Awaiting Admin Processing, Under Review 2021/11/17 Under review 2021/12/09 Under Review 2022/01/13 催稿信 2022/01/14 Major Revision 2022/01/17 补发Referee3意见 2022/02/23 Awaiting Admin Processing 2022/02/24 Minor revision, Awaiting Admin Processing, Under Review 2022/02/25 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Sun Feb 27 10:02:51 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564192, encodeId=09755641921f, content=你的文章怎么样了qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, beContent=qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=556b1436955, createdName=gunaibing, createdTime=Sat Dec 08 00:00:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583266, encodeId=a801583266da, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8月30投稿，国庆返修，大修给了3个月时间，2个reviewer+编辑部大大小小40+个问题，为了毕业咬牙补了2个实验，response写了近7k,文章最后几乎重写，截稿最后一天最后1个小时修回去，天天刷网页，好在一周后accept。不得不说，编辑都挺仔细的，希望今年能破5。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/a27b6b8db8d90fcd7110b426c39f0062/4ed52214cfc264eaf29fcd0493834b5b.jpg, createdBy=fd2f1702643, createdName=正经可乐, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581398, encodeId=df6758139879, content=请问大家如果作者单位没有搜索到该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/31/8d861a664fc3e3e6d49b017cf9a9307f.jpg, createdBy=dcfd5205856, createdName=但行好事莫问前程, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580294, encodeId=c4ba5802943c, content=怎么哪里都有你而且全是灌水发言 132****5832暂无昵称 2019-10-25 发表:: 求经验求分享132****5832暂无昵称 2019-10-25 00:00:00 发表: 求经验求分享, beContent=132****5832暂无昵称 2019-10-25 发表:: 求经验求分享, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/d8b6f67634df60e1fc4d6be63d990ad2.jpg, createdBy=da341701496, createdName=Jesny, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578780, encodeId=68065e8780bc, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569362, encodeId=2bd35693626e, content=问下后来接收了吗，特别感激178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗178ot344101(暂无昵称) 2018-03-28 00:00:00 发表: 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, beContent=178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/b1048959fe9b121edb8df1193c53299b.jpg, createdBy=f95e2215637, createdName=小龙虾哒哒, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=)]

2018-12-08 gunaibing

你的文章怎么样了qq2aedb0dd 2018-09-26 00:00:00 发表:
你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。

qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。

232 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2177893, encodeId=e24121e78939e, content=中科院分区太过分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Fri Dec 29 00:08:32 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159781, encodeId=65fb2159e8138, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经炎症 经验分享：5.5 submitted 5.8 Under review 5.10 Under Review 6.12 Major revision 8.23 submited 8.25 under review 9.1 Under Review 9.22 Awaiting Decision 9.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bda8651849, createdName=ms3000002118825560, createdTime=Tue Sep 26 11:05:43 CST 2023, time=2023-09-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=964796, encodeId=efdc964e9609, content=审稿速度:6.0 经验分享：4月16接收综述一篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Wed May 12 07:59:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197686, encodeId=e65b119e68614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;生物标志物 经验分享：IF 5.372 2021/11/16 Awaiting Admin Processing, Under Review 2021/11/17 Under review 2021/12/09 Under Review 2022/01/13 催稿信 2022/01/14 Major Revision 2022/01/17 补发Referee3意见 2022/02/23 Awaiting Admin Processing 2022/02/24 Minor revision, Awaiting Admin Processing, Under Review 2022/02/25 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Sun Feb 27 10:02:51 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564192, encodeId=09755641921f, content=你的文章怎么样了qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, beContent=qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=556b1436955, createdName=gunaibing, createdTime=Sat Dec 08 00:00:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583266, encodeId=a801583266da, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8月30投稿，国庆返修，大修给了3个月时间，2个reviewer+编辑部大大小小40+个问题，为了毕业咬牙补了2个实验，response写了近7k,文章最后几乎重写，截稿最后一天最后1个小时修回去，天天刷网页，好在一周后accept。不得不说，编辑都挺仔细的，希望今年能破5。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/a27b6b8db8d90fcd7110b426c39f0062/4ed52214cfc264eaf29fcd0493834b5b.jpg, createdBy=fd2f1702643, createdName=正经可乐, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581398, encodeId=df6758139879, content=请问大家如果作者单位没有搜索到该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/31/8d861a664fc3e3e6d49b017cf9a9307f.jpg, createdBy=dcfd5205856, createdName=但行好事莫问前程, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580294, encodeId=c4ba5802943c, content=怎么哪里都有你而且全是灌水发言 132****5832暂无昵称 2019-10-25 发表:: 求经验求分享132****5832暂无昵称 2019-10-25 00:00:00 发表: 求经验求分享, beContent=132****5832暂无昵称 2019-10-25 发表:: 求经验求分享, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/d8b6f67634df60e1fc4d6be63d990ad2.jpg, createdBy=da341701496, createdName=Jesny, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578780, encodeId=68065e8780bc, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569362, encodeId=2bd35693626e, content=问下后来接收了吗，特别感激178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗178ot344101(暂无昵称) 2018-03-28 00:00:00 发表: 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, beContent=178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/b1048959fe9b121edb8df1193c53299b.jpg, createdBy=f95e2215637, createdName=小龙虾哒哒, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=)]

2020-01-14 正经可乐

审稿速度:1.0 | 投稿命中率:50.0
经验分享：8月30投稿，国庆返修，大修给了3个月时间，2个reviewer+编辑部大大小小40+个问题，为了毕业咬牙补了2个实验，response写了近7k,文章最后几乎重写，截稿最后一天最后1个小时修回去，天天刷网页，好在一周后accept。不得不说，编辑都挺仔细的，希望今年能破5。

196 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2177893, encodeId=e24121e78939e, content=中科院分区太过分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Fri Dec 29 00:08:32 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159781, encodeId=65fb2159e8138, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经炎症 经验分享：5.5 submitted 5.8 Under review 5.10 Under Review 6.12 Major revision 8.23 submited 8.25 under review 9.1 Under Review 9.22 Awaiting Decision 9.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bda8651849, createdName=ms3000002118825560, createdTime=Tue Sep 26 11:05:43 CST 2023, time=2023-09-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=964796, encodeId=efdc964e9609, content=审稿速度:6.0 经验分享：4月16接收综述一篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Wed May 12 07:59:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197686, encodeId=e65b119e68614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;生物标志物 经验分享：IF 5.372 2021/11/16 Awaiting Admin Processing, Under Review 2021/11/17 Under review 2021/12/09 Under Review 2022/01/13 催稿信 2022/01/14 Major Revision 2022/01/17 补发Referee3意见 2022/02/23 Awaiting Admin Processing 2022/02/24 Minor revision, Awaiting Admin Processing, Under Review 2022/02/25 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Sun Feb 27 10:02:51 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564192, encodeId=09755641921f, content=你的文章怎么样了qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, beContent=qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=556b1436955, createdName=gunaibing, createdTime=Sat Dec 08 00:00:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583266, encodeId=a801583266da, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8月30投稿，国庆返修，大修给了3个月时间，2个reviewer+编辑部大大小小40+个问题，为了毕业咬牙补了2个实验，response写了近7k,文章最后几乎重写，截稿最后一天最后1个小时修回去，天天刷网页，好在一周后accept。不得不说，编辑都挺仔细的，希望今年能破5。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/a27b6b8db8d90fcd7110b426c39f0062/4ed52214cfc264eaf29fcd0493834b5b.jpg, createdBy=fd2f1702643, createdName=正经可乐, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581398, encodeId=df6758139879, content=请问大家如果作者单位没有搜索到该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/31/8d861a664fc3e3e6d49b017cf9a9307f.jpg, createdBy=dcfd5205856, createdName=但行好事莫问前程, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580294, encodeId=c4ba5802943c, content=怎么哪里都有你而且全是灌水发言 132****5832暂无昵称 2019-10-25 发表:: 求经验求分享132****5832暂无昵称 2019-10-25 00:00:00 发表: 求经验求分享, beContent=132****5832暂无昵称 2019-10-25 发表:: 求经验求分享, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/d8b6f67634df60e1fc4d6be63d990ad2.jpg, createdBy=da341701496, createdName=Jesny, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578780, encodeId=68065e8780bc, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569362, encodeId=2bd35693626e, content=问下后来接收了吗，特别感激178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗178ot344101(暂无昵称) 2018-03-28 00:00:00 发表: 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, beContent=178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/b1048959fe9b121edb8df1193c53299b.jpg, createdBy=f95e2215637, createdName=小龙虾哒哒, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=)]

2019-12-13 但行好事莫问前程

请问大家如果作者单位没有搜索到该怎么办？

221 0

[GetPortalCommentsPageByObjectIdResponse(id=2177893, encodeId=e24121e78939e, content=中科院分区太过分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Fri Dec 29 00:08:32 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159781, encodeId=65fb2159e8138, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经炎症 经验分享：5.5 submitted 5.8 Under review 5.10 Under Review 6.12 Major revision 8.23 submited 8.25 under review 9.1 Under Review 9.22 Awaiting Decision 9.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bda8651849, createdName=ms3000002118825560, createdTime=Tue Sep 26 11:05:43 CST 2023, time=2023-09-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=964796, encodeId=efdc964e9609, content=审稿速度:6.0 经验分享：4月16接收综述一篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Wed May 12 07:59:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197686, encodeId=e65b119e68614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;生物标志物 经验分享：IF 5.372 2021/11/16 Awaiting Admin Processing, Under Review 2021/11/17 Under review 2021/12/09 Under Review 2022/01/13 催稿信 2022/01/14 Major Revision 2022/01/17 补发Referee3意见 2022/02/23 Awaiting Admin Processing 2022/02/24 Minor revision, Awaiting Admin Processing, Under Review 2022/02/25 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Sun Feb 27 10:02:51 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564192, encodeId=09755641921f, content=你的文章怎么样了qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, beContent=qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=556b1436955, createdName=gunaibing, createdTime=Sat Dec 08 00:00:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583266, encodeId=a801583266da, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8月30投稿，国庆返修，大修给了3个月时间，2个reviewer+编辑部大大小小40+个问题，为了毕业咬牙补了2个实验，response写了近7k,文章最后几乎重写，截稿最后一天最后1个小时修回去，天天刷网页，好在一周后accept。不得不说，编辑都挺仔细的，希望今年能破5。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/a27b6b8db8d90fcd7110b426c39f0062/4ed52214cfc264eaf29fcd0493834b5b.jpg, createdBy=fd2f1702643, createdName=正经可乐, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581398, encodeId=df6758139879, content=请问大家如果作者单位没有搜索到该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/31/8d861a664fc3e3e6d49b017cf9a9307f.jpg, createdBy=dcfd5205856, createdName=但行好事莫问前程, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580294, encodeId=c4ba5802943c, content=怎么哪里都有你而且全是灌水发言 132****5832暂无昵称 2019-10-25 发表:: 求经验求分享132****5832暂无昵称 2019-10-25 00:00:00 发表: 求经验求分享, beContent=132****5832暂无昵称 2019-10-25 发表:: 求经验求分享, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/d8b6f67634df60e1fc4d6be63d990ad2.jpg, createdBy=da341701496, createdName=Jesny, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578780, encodeId=68065e8780bc, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569362, encodeId=2bd35693626e, content=问下后来接收了吗，特别感激178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗178ot344101(暂无昵称) 2018-03-28 00:00:00 发表: 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, beContent=178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/b1048959fe9b121edb8df1193c53299b.jpg, createdBy=f95e2215637, createdName=小龙虾哒哒, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=)]

2019-11-22 Jesny

怎么哪里都有你而且全是灌水发言 132****5832暂无昵称 2019-10-25 发表::
求经验求分享132****5832暂无昵称 2019-10-25 00:00:00 发表:
求经验求分享

132****5832暂无昵称 2019-10-25 发表:: 求经验求分享

178 0

[GetPortalCommentsPageByObjectIdResponse(id=2177893, encodeId=e24121e78939e, content=中科院分区太过分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Fri Dec 29 00:08:32 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159781, encodeId=65fb2159e8138, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经炎症 经验分享：5.5 submitted 5.8 Under review 5.10 Under Review 6.12 Major revision 8.23 submited 8.25 under review 9.1 Under Review 9.22 Awaiting Decision 9.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bda8651849, createdName=ms3000002118825560, createdTime=Tue Sep 26 11:05:43 CST 2023, time=2023-09-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=964796, encodeId=efdc964e9609, content=审稿速度:6.0 经验分享：4月16接收综述一篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Wed May 12 07:59:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197686, encodeId=e65b119e68614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;生物标志物 经验分享：IF 5.372 2021/11/16 Awaiting Admin Processing, Under Review 2021/11/17 Under review 2021/12/09 Under Review 2022/01/13 催稿信 2022/01/14 Major Revision 2022/01/17 补发Referee3意见 2022/02/23 Awaiting Admin Processing 2022/02/24 Minor revision, Awaiting Admin Processing, Under Review 2022/02/25 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Sun Feb 27 10:02:51 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564192, encodeId=09755641921f, content=你的文章怎么样了qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, beContent=qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=556b1436955, createdName=gunaibing, createdTime=Sat Dec 08 00:00:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583266, encodeId=a801583266da, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8月30投稿，国庆返修，大修给了3个月时间，2个reviewer+编辑部大大小小40+个问题，为了毕业咬牙补了2个实验，response写了近7k,文章最后几乎重写，截稿最后一天最后1个小时修回去，天天刷网页，好在一周后accept。不得不说，编辑都挺仔细的，希望今年能破5。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/a27b6b8db8d90fcd7110b426c39f0062/4ed52214cfc264eaf29fcd0493834b5b.jpg, createdBy=fd2f1702643, createdName=正经可乐, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581398, encodeId=df6758139879, content=请问大家如果作者单位没有搜索到该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/31/8d861a664fc3e3e6d49b017cf9a9307f.jpg, createdBy=dcfd5205856, createdName=但行好事莫问前程, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580294, encodeId=c4ba5802943c, content=怎么哪里都有你而且全是灌水发言 132****5832暂无昵称 2019-10-25 发表:: 求经验求分享132****5832暂无昵称 2019-10-25 00:00:00 发表: 求经验求分享, beContent=132****5832暂无昵称 2019-10-25 发表:: 求经验求分享, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/d8b6f67634df60e1fc4d6be63d990ad2.jpg, createdBy=da341701496, createdName=Jesny, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578780, encodeId=68065e8780bc, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569362, encodeId=2bd35693626e, content=问下后来接收了吗，特别感激178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗178ot344101(暂无昵称) 2018-03-28 00:00:00 发表: 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, beContent=178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/b1048959fe9b121edb8df1193c53299b.jpg, createdBy=f95e2215637, createdName=小龙虾哒哒, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

求经验求分享

204 0

[GetPortalCommentsPageByObjectIdResponse(id=2177893, encodeId=e24121e78939e, content=中科院分区太过分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6a65458119, createdName=ms1000001139242253, createdTime=Fri Dec 29 00:08:32 CST 2023, time=2023-12-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159781, encodeId=65fb2159e8138, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经炎症 经验分享：5.5 submitted 5.8 Under review 5.10 Under Review 6.12 Major revision 8.23 submited 8.25 under review 9.1 Under Review 9.22 Awaiting Decision 9.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bda8651849, createdName=ms3000002118825560, createdTime=Tue Sep 26 11:05:43 CST 2023, time=2023-09-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=964796, encodeId=efdc964e9609, content=审稿速度:6.0 经验分享：4月16接收综述一篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Wed May 12 07:59:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197686, encodeId=e65b119e68614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森病;生物标志物 经验分享：IF 5.372 2021/11/16 Awaiting Admin Processing, Under Review 2021/11/17 Under review 2021/12/09 Under Review 2022/01/13 催稿信 2022/01/14 Major Revision 2022/01/17 补发Referee3意见 2022/02/23 Awaiting Admin Processing 2022/02/24 Minor revision, Awaiting Admin Processing, Under Review 2022/02/25 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Sun Feb 27 10:02:51 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564192, encodeId=09755641921f, content=你的文章怎么样了qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, beContent=qq2aedb0dd 2018-09-26 00:00:00 发表: 你好，想请问下文章投出去后系统发出的要求所有作者确认文章内容和作者名单的邮件必须要回复吗？我最近才发现这个问题，文章已经投出去一段时间了，发邮件问编辑，也没收到回信。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=556b1436955, createdName=gunaibing, createdTime=Sat Dec 08 00:00:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583266, encodeId=a801583266da, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：8月30投稿，国庆返修，大修给了3个月时间，2个reviewer+编辑部大大小小40+个问题，为了毕业咬牙补了2个实验，response写了近7k,文章最后几乎重写，截稿最后一天最后1个小时修回去，天天刷网页，好在一周后accept。不得不说，编辑都挺仔细的，希望今年能破5。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/a27b6b8db8d90fcd7110b426c39f0062/4ed52214cfc264eaf29fcd0493834b5b.jpg, createdBy=fd2f1702643, createdName=正经可乐, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581398, encodeId=df6758139879, content=请问大家如果作者单位没有搜索到该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/31/8d861a664fc3e3e6d49b017cf9a9307f.jpg, createdBy=dcfd5205856, createdName=但行好事莫问前程, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580294, encodeId=c4ba5802943c, content=怎么哪里都有你而且全是灌水发言 132****5832暂无昵称 2019-10-25 发表:: 求经验求分享132****5832暂无昵称 2019-10-25 00:00:00 发表: 求经验求分享, beContent=132****5832暂无昵称 2019-10-25 发表:: 求经验求分享, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/d8b6f67634df60e1fc4d6be63d990ad2.jpg, createdBy=da341701496, createdName=Jesny, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578780, encodeId=68065e8780bc, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569362, encodeId=2bd35693626e, content=问下后来接收了吗，特别感激178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗178ot344101(暂无昵称) 2018-03-28 00:00:00 发表: 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, beContent=178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/b1048959fe9b121edb8df1193c53299b.jpg, createdBy=f95e2215637, createdName=小龙虾哒哒, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=)]

2019-04-10 小龙虾哒哒

问下后来接收了吗，特别感激178ot344101(暂无昵称) 2018-03-28 发表::
SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗178ot344101(暂无昵称) 2018-03-28 00:00:00 发表:
投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗

178ot344101(暂无昵称) 2018-03-28 发表:: SCI(2016)：4.083 SCI(2015)：3.842 SCI(2014)：4.281 投了14天了.是好消息还是坏消息.拒稿的话也需要一个月吗

214 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务